Home > Back to Publisher > Report Information

Psoriasis and Psoriatic Arthritis: A Strategic Analysis of the Market in the United States

Kalorama Information
September 1, 2006
254 Pages - SKU: KLI1189533

Abstract Table of Contents Search inside this report Related Reports Buy by the Section

Countries covered: United States

This report focuses on the applications of current and advanced therapeutics to the treatment of psoriasis and psoriatic arthritis, the options they present, and the progress that is being made in these fields. The major market effects of new therapeutics, with the potential of a breakthrough drug always a possibility, are expected to be seen over the next ten years. The technology trends selected in conjunction with the growing interest in psoriasis and its treatment present the most informative picture of advances in psoriasis and psoriatic arthritis therapeutics and the markets that result.

The report’s market analysis includes:

extensive discussion of the pathology of the multiple forms of the disease
thorough examination of the epidemiology in the United States segmented by severity and projected to 2016
comprehensive analysis of the total available market and serviceable available market for psoriasis (by severity) and psoriatic arthritis through 2016
monthly cost per patient forecasts for psoriasis (by severity) and psoriatic arthritis through 2016

In depth company profiles of major competitors and a meticulous review of the expert conclusions and strategic implications for competitors serious about winning in the psoriasis therapeutics field round out this systematic analysis.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including immunologists, dermatologists, rheumatologists, pathologists, research scientists, business development managers and marketing managers.

Chapter One: Executive Summary

Overview
Types
Scope and Methodology
Market Analysis
Trends and Considerations

CHAPTER Two: Pathology and Epidemiology

Overview
- Tumor Necrosis Factor á
- Contributing Factors
- National Psoriasis Foundation Survey
- Daily Life Impacts
- Problems Receiving Services Due to Perception of Their Disease
- Quality of Life
Pathology of Psoriasis
- Types
- Plaque Psoriasis
- Guttate Psoriasis
- Inverse Psoriasis
- Pustular Psoriasis
- Erythrodermic Psoriasis
- Types by Location
- Scalp Psoriasis
- Types by Severity
Pathology of Psoriatic Arthritis
The Genetics of Psoriasis and Psoriatic Arthritis
Psoriasis and Psoriatic Arthritis Epidemiology

CHAPTER Three: Current Therapies

Topical Therapy
- Anthralin
- Calcipotriene
- Coal Tar
- Salicylic Acid
- Corticosteroids (Steroids)
- Vitamin A
- Sunlight and Water (Climatotherapy)
Phototherapy
- UV-B Therapy
- PUVA
Systemic Treatments
- Corticosteroids
- Cyclosporine
- Methotrexate
- Retinoids
- Aspirin and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Biological DMARDS
- T-Cell Agents
- Monoclonal TNF Antibodies
- Soluble TNF Receptor Inhibitors
New Developments
Alternative Therapies
- Acupuncture
- Ayurvedic Medicine
- Chinese Medicine
- Chiropractic
- Homeopathic Medicine
- Naturopathic Medicine
- Glucosamine and Chondroitin
- Methylsulfonylmethane (MSM)
- S-adenosylmethionine (SAM-e)
- Magnetic Therapy

CHAPTER Four: Market Analysis

Forecasting Challenges
Market Size and Cost of Treatment
Total Available Market vs Serviceable Available Market
Competition

CHAPTER Five: Company Profiles

Amgen
Angiotech Pharmaceuticals
Biogen IDEC
Centocor, Inc.
Galderma Laboratories
Isis Pharmaceuticals, Inc.
Isotechnika, Inc.
Ligand Pharmaceuticals
Vertex Pharmaceuticals

CHAPTER Six: Conclusions and Strategic Implications

First Conclusion
Implications:
Second Conclusion
Implications:
Third Conclusion
Implications:
Fourth Conclusion
Implications:
Fifth Conclusion
Implications:
Sixth Conclusion
Implications:
Seventh Conclusion
Implications:
Eighth Conclusion
Implications:
Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

Table 1-1: Prevalence of Psoriasis and Psoriatic Arthritis in the United
States 2006-2016
Figure 1-1: Distribution of Psoriasis Cases in the United States by Severity: 2006
Table 1-2: Common Psoriasis Treatments
Table 1-3: The Total Available Market for Psoriasis and Psoriatic Arthritis Therapeutics in the United States by Severity 2006-2016
Figure 1-2: Trending in the Total Available Market (TAM) for Psoriasis and Psoriatic Arthritis Therapeutics in the United States: 2006-2016
Table 1-4: Serviceable Available Market (SAM) for Psoriasis and Psoriatic
Arthritis Therapeutics in the United States by Severity 2006-2016
Figure 4-3: Trending in the Serviceable Available Market (SAM) for Psoriasis and Psoriatic Arthritis Therapeutics in the United States: 2006-2016

CHAPTER Two: Pathology and Epidemiology

Table 2-1: Types of Psoriasis and Their Characteristics
Table 2-2: Psoriasis Assessment Methods
Table 2-3: Type of Psoriatic Arthritis (PsA) and Their Characteristics
Table 2-4: Prevalence of Psoriasis and Psoriatic Arthritis in the United States by Type 2006-2016
Figure 2-1: Prevalence of Psoriasis, by Severity, in the United States 2006-2016
Figure 2-2: Prevalence of Psoriasis and Psoriatic Arthritis in the United
States 2006-2016

CHAPTER Three: Current Therapies

Table 3-1: Psoriasis and Psoriatic Arthritis Therapeutics and Treatment
Products
Table 3-2: The Psoriasis Treatment Ladder
Table 3-3: Steroid Potency Classes and Products
Table 3-4: Phototherapy Skin Types
Table 3-5: Phototherapy Equipment Manufacturers
Table 3-6: Comparison of Biological Therapeutics for Psoriasis and Psoriatic Arthritis
Table 3-7: Treatments in Development for Psoriasis and Psoriatic Arthritis

CHAPTER Four: Market Analysis

Table 4-1: Total Available Market (TAM) for Psoriasis (by Severity) and
Psoriatic Arthritis Therapeutics in the United States 2006-2016
Figure 4-1: Trending in the Total Available Market (TAM) for Psoriasis and Psoriatic Arthritis Therapeutics in the United States: 2006-2016
Figure 4-2: Composition of the Total Available Market (TAM) for Psoriasis and Psoriatic Arthritis Therapeutics in the United States: 2006-2016
Table 4-2: Estimated Monthly Cost per Patient for the Medicinal Treatment of Psoriasis (by Severity) and Psoriatic Arthritis in the United States 2006-2016
Table 4-3: Serviceable Available Market (SAM) for Psoriasis (by Severity) and Psoriatic Arthritis Therapeutics in the United States: 2006-2016
Figure 4-3: Trending in the Serviceable Available Market (SAM) for Psoriasis and Psoriatic Arthritis Therapeutics in the United States 2006-2016
Figure 4-4: Composition of the Serviceable Available Market (SAM) for Psoriasis and Psoriatic Arthritis Therapeutics in the United States 2006-2016
Table 4-4: Active Competitors in Ethical Pharmaceuticals for Psoriasis and Psoriatic Arthritis in the United States
Figure 4-3: Trending in Average Monthly Medicinal Treatment Costs for Psoriasis (by Severity) and Psoriatic Arthritis: 2006-2016

More United States Rheumatology/Arthritis Reports

U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments by Frost & Sullivan
This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service ...

US Markets for Large-Joint Reconstructive Implants 2010 by Millennium Research Group
The US large-joint reconstructive implant market is large and well established. Nevertheless, as more patients—both over and under the age of 65— pursue large-joint replacement ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

Psoriasis and Psoriatic Arthritis: A Strategic Analysis of the Market in the United States

Share this report

Other tasks

Research Assistance

Related Markets

Rheumatology/Arthritis Reports

Free Alert Me service